Download
s13018-021-02678-x.pdf 1,41MB
WeightNameValue
1000 Titel
  • Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis
1000 Autor/in
  1. Migliorini, Filippo |
  2. Maffulli, Nicola |
  3. Colarossi, Giorgia |
  4. Eschweiler, Jörg |
  5. Tingart, Markus |
  6. Betsch, Marcel |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-08-27
1000 Erschienen in
1000 Quellenangabe
  • 16(1):533
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13018-021-02678-x |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393477/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Osteoporosis affects mostly postmenopausal women, leading to deterioration of the microarchitectural bone structure and low bone mass, with an increased fracture risk with associated disability, morbidity and mortality. This Bayesian network meta-analysis compared the effects of current anti-osteoporosis drugs on bone mineral density.!##!Methods!#!The present systematic review and network meta-analysis follows the PRISMA extension statement to report systematic reviews incorporating network meta-analyses of health care interventions. The literature search was performed in June 2021. All randomised clinical trials that have investigated the effects of two or more drug treatments on BMD for postmenopausal osteoporosis were accessed. The network comparisons were performed through the STATA Software/MP routine for Bayesian hierarchical random-effects model analysis. The inverse variance method with standardised mean difference (SMD) was used for analysis.!##!Results!#!Data from 64 RCTs involving 82,732 patients were retrieved. The mean follow-up was 29.7 ± 19.6 months. Denosumab resulted in a higher spine BMD (SMD -0.220; SE 3.379), followed by pamidronate (SMD -5.662; SE 2.635) and zoledronate (SMD -10.701; SE 2.871). Denosumab resulted in a higher hip BMD (SMD -0.256; SE 3.184), followed by alendronate (SMD -17.032; SE 3.191) and ibandronate (SMD -17.250; SE 2.264). Denosumab resulted in a higher femur BMD (SMD 0.097; SE 2.091), followed by alendronate (SMD -16.030; SE 1.702) and ibandronate (SMD -17.000; SE 1.679).!##!Conclusion!#!Denosumab results in higher spine BMD in selected women with postmenopausal osteoporosis. Denosumab had the highest influence on hip and femur BMD.!##!Level of evidence!#!Level I, Bayesian network meta-analysis of RCTs.
1000 Sacherschließung
lokal Systematic Review
lokal Bone Density [MeSH]
lokal Denosumab/physiology [MeSH]
lokal Female [MeSH]
lokal Osteoporosis [MeSH]
lokal Pharmaceutical Preparations [MeSH]
lokal Osteoporosis, Postmenopausal/diagnostic imaging [MeSH]
lokal Humans [MeSH]
lokal Ibandronic Acid/chemistry [MeSH]
lokal Osteoporosis, Postmenopausal/drug therapy [MeSH]
lokal Bayes Theorem [MeSH]
lokal Osteoporosis
lokal Alendronate/chemistry [MeSH]
lokal Network Meta-Analysis [MeSH]
lokal Bone Density Conservation Agents/therapeutic use [MeSH]
lokal Denosumab
lokal Drugs
lokal Bone mineral density
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0001-7220-1221|https://frl.publisso.de/adhoc/uri/TWFmZnVsbGksIE5pY29sYQ==|https://frl.publisso.de/adhoc/uri/Q29sYXJvc3NpLCBHaW9yZ2lh|https://frl.publisso.de/adhoc/uri/RXNjaHdlaWxlciwgSsO2cmc=|https://frl.publisso.de/adhoc/uri/VGluZ2FydCwgTWFya3Vz|https://frl.publisso.de/adhoc/uri/QmV0c2NoLCBNYXJjZWw=
1000 Hinweis
  • DeepGreen-ID: a9aa7784b3804ee59a7dcf064c1def35 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6463505.rdf
1000 Erstellt am 2023-11-15T19:02:09.570+0100
1000 Erstellt von 322
1000 beschreibt frl:6463505
1000 Zuletzt bearbeitet 2023-11-30T21:47:29.668+0100
1000 Objekt bearb. Thu Nov 30 21:47:29 CET 2023
1000 Vgl. frl:6463505
1000 Oai Id
  1. oai:frl.publisso.de:frl:6463505 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source